Rockefeller Capital Management’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $32.6K | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $249K | Sell |
|
|||||
|
2022
Q4 | $379K | Buy |
|
|||||
|
2022
Q3 | $282K | Buy |
|
|||||
|
2022
Q2 | $206K | Buy |
|
|||||
|
2022
Q1 | $247K | Sell |
|
|||||
|
2021
Q4 | $292K | Buy |
|
|||||
|
2021
Q3 | $136K | Sell |
|
|||||
|
2021
Q2 | $149K | Buy |
|
|||||
|
2021
Q1 | $172K | Sell |
|
|||||
|
2020
Q4 | $560K | Buy |
|
|||||
|
2020
Q3 | $177K | Buy |
|
|||||
|
2020
Q2 | $165K | Hold |
|
|||||
|
2020
Q1 | $94K | Sell |
|
|||||
|
2019
Q4 | $110K | Sell |
|
|||||
|
2019
Q3 | $117K | Sell |
|
|||||
|
2019
Q2 | $178K | Buy |
|
|||||
|
2019
Q1 | $156K | Buy |
|
|||||
|
2018
Q4 | $92K | Hold |
|
|||||
|
2018
Q3 | $162K | Hold |
|
|||||
|
2018
Q2 | $163K | Hold |
|
|||||
|
2018
Q1 | $108K | Buy |
|